,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-05-22 03:47:00,"Chicago, IL - May 22, 2018 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.01857645809650421,0.008504743687808514,0.9729188084602356,neutral,0.010071714408695698
1,2018-05-22 03:47:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2018-05-22 03:47:00,"Stocks recently featured in the blog include Procter & GamblePG , AbbVieABBV , McDonald'sMCD and PepsiCoPEP .",0.02817940153181553,0.010935612954199314,0.9608850479125977,neutral,0.01724378764629364
3,2018-05-22 03:47:00,"Here are highlights from Monday's Analyst Blog:

The Zacks Research Daily presents the best research output of our analyst team.",0.24418438971042633,0.009908846579492092,0.7459067702293396,neutral,0.23427554965019226
4,2018-05-22 03:47:00,"Today's Research Daily features new research reports on 17 major stocks, including Procter & Gamble, AbbVie, McDonald's and PepsiCo.",0.04341910406947136,0.009471741504967213,0.9471091032028198,neutral,0.03394736349582672
5,2018-05-22 03:47:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
6,2018-05-22 03:47:00,Procter & Gamble 's shares have underperformed the Zacks Soap and Cleaning Materials industry over the last six months (-16.9% vs. -10.2%).,0.13728287816047668,0.837239146232605,0.025477929040789604,negative,-0.6999562978744507
7,2018-05-22 03:47:00,"P&G reported third-quarter fiscal 2018 results, wherein earnings and revenues surpassed expectations, benefiting from higher demand for skincare products, along with fabric and home care products.",0.9514551162719727,0.019007151946425438,0.029537636786699295,positive,0.9324479699134827
8,2018-05-22 03:47:00,"Adjusted earnings grew 4% from the year-ago level, aided by productivity cost savings.",0.9594029784202576,0.02114647440612316,0.019450554624199867,positive,0.9382565021514893
9,2018-05-22 03:47:00,"Top line grew 4% on organic sales growth of 1%, comprising 2% volume growth.",0.9267733097076416,0.015397715382277966,0.05782897397875786,positive,0.9113755822181702
10,2018-05-22 03:47:00,"The Zacks analyst emphasizes that Procter & Gamble remains focused on improved product, packaging and marketing initiatives, and productivity cost-savings plan.",0.9255908727645874,0.014272629283368587,0.06013648211956024,positive,0.9113182425498962
11,2018-05-22 03:47:00,"Meanwhile, it intends to acquire the consumer-health unit of Merck KGaA, which will enhance P&G's existing consumer healthcare capabilities.",0.9276061654090881,0.01264186017215252,0.05975199490785599,positive,0.9149643182754517
12,2018-05-22 03:47:00,"However, core gross and operating margin declined 110 bps and 100 bps, respectively, in the quarter.",0.016953766345977783,0.9722655415534973,0.010780775919556618,negative,-0.9553117752075195
13,2018-05-22 03:47:00,"Lower pricing, higher commodity costs and increased competition continued to hurt results.",0.017327021807432175,0.9681260585784912,0.014546944759786129,negative,-0.9507990479469299
14,2018-05-22 03:47:00,P&G's shares have lost around 20.1% year to date.,0.017447376623749733,0.9721338152885437,0.010418795980513096,negative,-0.9546864628791809
15,2018-05-22 03:47:00,"Estimates for fiscal 2018 and 2019 have moved down 0.2% and 1.3%, over the past 60 days.",0.017308732494711876,0.9634294509887695,0.01926175318658352,negative,-0.9461207389831543
16,2018-05-22 03:47:00,"Shares of AbbVie have gained +9.6% year to date, outperforming the Zacks Large Cap Pharmaceuticals industry, which has declined -3.8% over the same period.",0.9164493083953857,0.06528012454509735,0.018270552158355713,positive,0.8511691689491272
17,2018-05-22 03:47:00,AbbVie beat estimates for both earnings and sales in the first quarter.,0.9299854040145874,0.0444299578666687,0.02558463253080845,positive,0.8855554461479187
18,2018-05-22 03:47:00,It also raised its earnings expectations for 2018 based on strong Q1 performance and an optimistic outlook for future quarters.,0.926563560962677,0.01623469404876232,0.05720178410410881,positive,0.9103288650512695
19,2018-05-22 03:47:00,"AbbVie's key drug, Humira, has been performing well based on strong demand trends, despite new competition.",0.9525672197341919,0.01993987150490284,0.027492882683873177,positive,0.9326273202896118
20,2018-05-22 03:47:00,"Moreover, Imbruvica has multibillion dollar potential and AbbVie is exploring the possibility of label expansion into solid tumors and autoimmune diseases.",0.711133599281311,0.009994653053581715,0.2788717746734619,positive,0.701138973236084
21,2018-05-22 03:47:00,Mavyret's launch has also been stronger than expected.,0.9519012570381165,0.020478853955864906,0.027619916945695877,positive,0.9314224123954773
22,2018-05-22 03:47:00,AbbVie has an impressive late-stage pipeline with label expansions for both new and existing products expected over the next few years.,0.8751019835472107,0.010924117639660835,0.11397386342287064,positive,0.8641778826713562
23,2018-05-22 03:47:00,The Zacks analyst thinks promising data from several pivotal studies and settlement of its second Humira patent dispute with Biogen are key positives.,0.8871339559555054,0.016172025352716446,0.09669408202171326,positive,0.8709619045257568
24,2018-05-22 03:47:00,"However, Viekira's sales continue to be hurt by intensifying competition.",0.020402133464813232,0.9611741304397583,0.018423741683363914,negative,-0.9407719969749451
25,2018-05-22 03:47:00,"McDonald 's shares have gained +8.6% over the past one year, outperforming the Zacks Restaurants industry which has gained +1.7% over the same period.",0.954350471496582,0.02583380974829197,0.019815707579255104,positive,0.928516685962677
26,2018-05-22 03:47:00,"The Zacks analyst thinks McDonald's impressive earnings surprise history, various sales and digital initiatives as well as positive comparable sales are major positives.",0.9099383354187012,0.01743607223033905,0.0726255476474762,positive,0.8925022482872009
27,2018-05-22 03:47:00,"Earnings surpassed the estimate for 15th straight quarter, as it reported first-quarter 2018 results.",0.9493451118469238,0.024562504142522812,0.026092447340488434,positive,0.9247826337814331
28,2018-05-22 03:47:00,"Furthermore, increased focus on delivery and accelerated deployment of Experience of the Future restaurants in the United States should boost its performance.",0.955446720123291,0.017465371638536453,0.027087954804301262,positive,0.937981367111206
29,2018-05-22 03:47:00,Efforts to attract customers in International Lead & High Growth Markets also bode well.,0.9319196939468384,0.013546347618103027,0.054534051567316055,positive,0.9183733463287354
30,2018-05-22 03:47:00,"In fact, global comps at McDonald's have been positive over the trailing eleven quarters.",0.9402585625648499,0.019702425226569176,0.04003896564245224,positive,0.9205561280250549
31,2018-05-22 03:47:00,"Yet, high labor costs and currency headwinds are major concerns.",0.02880323864519596,0.8128318190574646,0.158364936709404,negative,-0.7840285897254944
32,2018-05-22 03:47:00,"Moreover, revenues have been under pressure for quite some time due to strategic refranchising initiative.",0.04195807874202728,0.8760879039764404,0.08195402473211288,negative,-0.834129810333252
33,2018-05-22 03:47:00,"Even so, its augmented focus on refranchising should cut the capital requirements and facilitate EPS growth in the long run.",0.9347371459007263,0.031617797911167145,0.03364509716629982,positive,0.9031193256378174
34,2018-05-22 03:47:00,"Shares of PepsiCo have decreased -18.7% year to date, underperforming the Zacks Soft Beverages industry, which has declined -12.3% over the same period.",0.018416162580251694,0.9717870950698853,0.009796787984669209,negative,-0.9533709287643433
35,2018-05-22 03:47:00,PepsiCo's first-quarter 2018 earnings and revenues both beat expectations.,0.9471576809883118,0.027166452258825302,0.0256758201867342,positive,0.9199912548065186
36,2018-05-22 03:47:00,"Notably, this is the eighth consecutive quarter of positive earnings surprise.",0.8907742500305176,0.06601406633853912,0.043211791664361954,positive,0.8247601985931396
37,2018-05-22 03:47:00,"The improvement was mainly due to strong performances in its international divisions, propelled by higher revenue growth in the developing and emerging markets.",0.9591833353042603,0.017967145889997482,0.022849449887871742,positive,0.9412161707878113
38,2018-05-22 03:47:00,"Core earnings and revenues grew 3% and 4.3% year over year, respectively.",0.9570862054824829,0.021370574831962585,0.021543210372328758,positive,0.9357156157493591
39,2018-05-22 03:47:00,"Organic revenues were 2.3% in the quarter, same as the prior quarter.",0.24746073782444,0.31251221895217896,0.44002699851989746,neutral,-0.06505148112773895
40,2018-05-22 03:47:00,"However, NAB division reported dismal results with revenues and operating profit decreasing 1% and 22%, respectively.",0.02102813310921192,0.9692092537879944,0.009762585163116455,negative,-0.9481810927391052
41,2018-05-22 03:47:00,"Volumes declined 2.5%, led by 4% decline in CSDs and 1% decrease in Non CSDs.",0.02265704981982708,0.9689568281173706,0.008386165834963322,negative,-0.9462997913360596
42,2018-05-22 03:47:00,Shift in consumer preferences toward healthier options is a potent headwind.,0.053230077028274536,0.8930668234825134,0.05370311439037323,negative,-0.8398367166519165
43,2018-05-22 03:47:00,"Earnings estimates have moved 0.2% and 0.5% south for 2018 and 2019, respectively, over the past 30 days.",0.6503737568855286,0.1978675127029419,0.15175870060920715,positive,0.45250624418258667
44,2018-05-22 03:47:00,Looking for Stocks with Skyrocketing Upside?,0.09469357132911682,0.09826507419347763,0.807041347026825,neutral,-0.0035715028643608093
45,2018-05-22 03:47:00,Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.,0.41462862491607666,0.01087752915918827,0.5744938254356384,neutral,0.40375110507011414
46,2018-05-22 03:47:00,"Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021.",0.8838319182395935,0.03136736899614334,0.08480073511600494,positive,0.8524645566940308
47,2018-05-22 03:47:00,"Early investors stand to make a killing, but you have to be ready to act and know just where to look.",0.19955629110336304,0.018484661355614662,0.781959056854248,neutral,0.18107162415981293
48,2018-05-22 03:47:00,"See the pot trades we're targeting>>

Past performance is no guarantee of future results.",0.08467736095190048,0.0530620776116848,0.8622605800628662,neutral,0.03161528334021568
49,2018-05-22 03:47:00,Inherent in any investment is the potential for loss .,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
50,2018-05-22 03:47:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
51,2018-05-22 03:47:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
52,2018-05-22 03:47:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
53,2018-05-22 03:47:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
54,2018-05-22 03:47:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
55,2018-05-22 03:47:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
56,2018-05-22 03:47:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
57,2018-05-22 03:47:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
58,2018-05-22 03:47:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
59,2018-05-22 03:47:00,Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01104306522756815,0.014137434773147106,0.9748194813728333,neutral,-0.0030943695455789566
60,2018-05-22 03:47:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
61,2018-05-22 03:47:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
62,2018-05-22 03:47:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
63,2018-05-22 03:47:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
